Aurobindo Pharma USA acquires Lannett Company LLC for $250 million, expanding U.S. manufacturing capabilities and product ...

The transaction is valued at an enterprise value of $250 million (₹21,850 crore) on a cash-free, debt-free basis, including ...

Hyderabad: In a major strategic move, Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Aurobindo ...

Aurobindo Pharma to acquire US-based Lannett for $250M, gaining a strategic local manufacturing base to offset tariffs and ...

The deal is being carried out on a cash-free, debt-free basis, factoring in standardised working capital levels.

Hyderabad: Amid rising fears of US President Donald Trump imposing tariffs on Indian pharma imports, Aurobindo Pharma is ...

Aurobindo Pharma's shares fell by 2.22% to Rs 1,114.50 in early trading. Despite consistent financial growth, the stock is currently trading lower than its previous close.

With the stock currently trading at Rs 1,114.50, Aurobindo Pharma experiences a decline in the early trading session.

Pharma After multiple wrist-slaps, Aurobindo unit Eugia receives another manufacturing write-up By Fraiser Kansteiner Mar 4, 2024 10:34am Aurobindo Pharma India U.S. FDA Form 483 ...